Profile: Velocimed, Inc. specializes in the development and commercialization of minimally invasive cardiovascular & neurovascular medical devices. We have FDA approval to begin our first investigational device exemption (IDE) clinical trial for the Proxis™ embolic protection system, the first proximal embolic protection device designed for coronary applications. The design of the Proxis™ embolic protection system allows it to give complete embolic protection.